A new class of diabetes medicines is heavily advertised on TV and shows great promise in getting patients’ blood sugar levels down, but a safety announcement from the Food and Drug Administration warns that one of the drugs, Johnson & Johnson’s Invokana, doubles those patients’ chance of needing parts of their legs or feet amputated.
People with diabetes are already at risk of having lower limbs amputated because of circulatory and nerve damage that the disease does over time. However, in two clinical trials of the drug canagliflozin, marketed as Invokana, Invokamet, and Invokamet XR, patients taking the drug were twice as likely to need amputations.
https://consumerist.com/2017/05/17/d...eg-amputation/
People with diabetes are already at risk of having lower limbs amputated because of circulatory and nerve damage that the disease does over time. However, in two clinical trials of the drug canagliflozin, marketed as Invokana, Invokamet, and Invokamet XR, patients taking the drug were twice as likely to need amputations.
https://consumerist.com/2017/05/17/d...eg-amputation/
Comment